Trial Details
TERMINATEDBasic Information
| Clinical ID | c1519 |
|---|---|
| Identifier | NCT03768219 |
| Trial Title | Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Psoriasis|Ulcerative Colitis |
| Interventions | BIOLOGICAL: APVO210|BIOLOGICAL: Placebo |
Participant Information
| Sponsor | Aptevo Therapeutics |
|---|---|
| City | Melbourne |
| Country/Region | Australia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2019-03-18 |
|---|---|
| Primary Completion Date | 2020-06-30 |
| Completion Date | 2020-06-30 |